Private Equity Firms in New York
43 mid-market firms headquartered in New York. Sector focus, check size, and investment criteria for each, drawn from the firms' own published materials.
- Assured Healthcare Partners
Exclusively healthcare, with a preference for provider services businesses that do not carry direct reimbursement risk.
- BelHealth Investment Partners
A New York healthcare investor spanning services, products, and distribution at the smaller end of the market.
- Brand Velocity Group
A New York consumer specialist that buys brands with $10M+ EBITDA and applies a marketing-led playbook.
- Branford Castle Partners
A New York firm hunting below the radar: specialty manufacturing, industrials, and transportation companies up to $15M EBITDA with a $3M to $10M sweet spot.
- Bregal Partners
The North American lower-middle-market arm of the Bregal family, backing founder-owned consumer, multi-unit, food, and business services companies up to $75M of EBITDA.
- Bregal Sagemount
Sagemount invests $20M to $400M in growth companies across software, tech-enabled services, healthcare IT, and fintech, needing only $7M of revenue to engage.
- Bruckmann, Rosser, Sherrill & Co. (BRS)
BRS has been doing consumer and multi-unit deals in New York since 1995, from restaurant groups to specialty distribution, across a wide $1M to $25M EBITDA range.
- Centre Partners
One of New York's veteran mid-market shops, focused on founder- and family-owned consumer and healthcare companies with $5M to $40M of EBITDA.
- CIP Capital
A New York firm investing $25M to $125M in tech-enabled business services, business information, and knowledge services companies with $5M to $25M+ of EBITDA.
- Coalesce Capital
A newer New York firm with a $900M debut fund focused on human-capital-driven and tech-enabled services: compliance, facility services, HR outsourcing.
- Concord Health Partners
A healthcare investor with an unusual LP base that includes the American Hospital Association, giving portfolio companies direct access to hospital-system buyers.
- Consonance Capital Partners
New York healthcare-only investors focused exclusively on the U.S.
- Consumer Growth Partners
A White Plains specialist in specialty retail and branded consumer products with at least $2M of EBITDA.
- Dunes Point Capital
A Rye, New York family office turned institutional investor, buying industrial technology and building products platforms with $10M to $75M of EBITDA and bolting on companies from $2M up.
- Enhanced Healthcare Partners
A New York healthcare-only firm whose $521M second fund closed oversubscribed in 2025.
- Garnett Station Partners
A New York firm built on multi-site consumer: restaurants, car washes, health services, franchise platforms.
- GenNx360 Capital Partners
A New York firm buying industrial services, manufacturing, transportation, and logistics companies with $5M to $35M of EBITDA.
- Grant Avenue Capital
A New York healthcare firm led by a former Apax healthcare partner, with $623M AUM across services and medical products.
- Graycliff Partners
A New York firm descended from HSBC's private capital arm, investing $10M to $100M in niche manufacturing, distribution, and industrial services companies with $4M to $50M of EBITDA.
- Health Enterprise Partners
A New York healthcare IT investor whose LP base includes dozens of hospital systems and health plans, which double as customer introductions for portfolio companies.
- High Road Capital Partners
A New York firm buying niche manufacturing, distribution, and services companies with $1M to $10M of EBITDA.
- ICV Partners
A New York firm investing in business services, non-discretionary consumer services, and food companies with $5M to $15M of EBITDA.
- InTandem Capital Partners
A New York healthcare services firm with a $715M third fund, focused on provider services businesses without direct reimbursement exposure.
- Lead Edge Capital
A New York growth firm with a $3.5B seventh fund investing $50M to $400M in software and internet businesses with $10M+ revenue.
- Long Ridge Equity Partners
A New York firm investing $25M to $150M in financial and business technology companies with $5M+ revenue.
- MidOcean Partners
A New York firm with $11B+ AUM investing $50M to $300M+ in consumer and business services companies with enterprise values from $150M to $750M+.
- New MainStream Capital
A New York firm (often shortened to NMS Capital) investing $25M to $75M in healthcare and business services companies with $5M to $25M of EBITDA.
- NexPhase Capital
A New York firm with $2.6B raised, running thesis-driven plays across healthcare, software, and consumer.
- Palladium Equity Partners
A New York firm with ~$3.6B AUM investing $50M to $150M in consumer, services, industrial, and healthcare companies with $10M to $75M of EBITDA.
- Prelude Growth Partners
A New York consumer growth firm with a $600M third fund, investing $15M to $75M in high-growth beauty, wellness, and food brands.
- Radian Capital
A New York firm investing $10M to $60M in B2B software and services companies with $5M+ ARR.
- Regal Healthcare Capital Partners
A New York healthcare services firm whose $610M fourth fund closed above target in 2026.
- Saw Mill Capital
A Briarcliff Manor firm investing $15M to $100M per platform in engineered products, specialty distribution, and industrial services companies with $3M to $25M of EBITDA.
- Spire Capital
A New York firm investing $15M to $125M in tech-enabled business services, media, education, and communications companies from $2M of EBITDA.
- Stellex Capital Management
A New York and London firm investing $75M to $150M in industrial, consumer, and food businesses, with real appetite for operational complexity, carve-outs, and turnarounds.
- Tenex Capital Management
A New York firm with a $1.9B fourth fund investing $25M to $125M in industrials, services, and healthcare companies with $3M to $40M of EBITDA.
- The Riverside Company
One of the largest small-company investors in the world, with strategies spanning micro-cap (under $10M EBITDA), capital appreciation ($10M to $35M), flexible capital, and software acceleration.
- Topspin Consumer Partners
A Mamaroneck firm investing $10M to $50M in consumer companies across wellness, personal care, food, pet, and children's products with EBITDA up to $25M.
- TZP Group
A New York firm managing ~$2B across strategies, investing $10M to $100M in consumer and business services companies with $2M to $15M of EBITDA.
- V&A Capital (Vanda Capital)
A New York firm buying manufacturing, distribution, and transportation businesses with $1M to $10M of EBITDA.
- Vertica Capital Partners
A New York software firm with $1B+ AUM investing $15M to $200M in enterprise and vertical software companies with $2M to $20M of ARR.
- Vesey Street Capital Partners
A New York healthcare services firm with ~$942M AUM investing $75M to $120M in businesses with $10M to $20M of EBITDA.
- Zenyth Partners
A New York healthcare firm with a $375M second fund building consumer-facing healthcare services platforms: dental, vision, MSK, and similar multi-site categories.